Skip to main content
SpringerLink
Log in

Glycogen Storage Disease, Type II

  • Reference work entry
Atlas of Genetic Diagnosis and Counseling

  • 272 Accesses

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution

Institutional subscriptions

References

  • ACMG Work Group on Management of Pompe Disease, Kishnani, P. S., Steiner, R. D., Bali, D., et al. (2006). Pompe disease diagnosis and management guideline. Genetics in Medicine, 8, 267–288.

    Article  PubMed  Google Scholar 

  • Amalfitano, A., Bengur, A. R., Morse, R. P., et al. (2001). Recombinant human acid alpha-glucosidase enzyme therapy for infantile glycogen storage disease type II: Results of a phase I/II clinical trial. Genetics in Medicine, 3, 132–138.

    Article  PubMed  CAS  Google Scholar 

  • Amalfitano, A., McVie-Wylie, A. J., Hu, H., et al. (1999). Systemic correction of the muscle disorder glycogen storage disease type II after hepatic targeting of a modified adenovirus vector encoding human acid-alpha-glucosidase. Proceedings of the National Academy of Sciences of the United States of America, 96, 8861–8866.

    Article  PubMed  CAS  Google Scholar 

  • Amato, A. A. (2000). Acid maltase deficiency and related myopathies. Neurologic Clinics, 18, 151–165.

    Article  PubMed  CAS  Google Scholar 

  • American Association of Neuromuscular & Electrodiagnostic Medicine. (2009). Diagnostic criteria for late-onset (childhood and adult) Pompe disease. Muscle & Nerve, 40, 149–160.

    Article  Google Scholar 

  • Ausems, M. G., Kroos, M. A., Van der Kraan, M., et al. (1996). Homozygous deletion of exon 18 leads to degradation of the lysosomal alpha-glucosidase precursor and to the infantile form of glycogen storage disease type II. Clinical Genetics, 49, 325–328.

    Article  PubMed  CAS  Google Scholar 

  • Ausems, M. G., Lochman, P., van Diggelen, O. P., et al. (1999). A diagnostic protocol for adult-onset glycogen storage disease type II. Neurology, 52, 851–853.

    PubMed  CAS  Google Scholar 

  • Ausems, M. G., ten Berg, K., Beemer, F. A., et al. (2000). Phenotypic expression of late-onset glycogen storage disease type II: Identification of asymptomatic adults through family studies and review of reported families. Neuromuscular Disorders, 10, 467–471.

    Article  PubMed  CAS  Google Scholar 

  • Ausems, M. G., Verbiest, J., Hermans, M. P., et al. (1999). Frequency of glycogen storage disease type II in The Netherlands: Implications for diagnosis and genetic counselling. European Journal of Human Genetics, 7, 713–716.

    Article  PubMed  CAS  Google Scholar 

  • Becker, J. A., Vlach, J., Raben, N., et al. (1998). The African origin of the common mutation in African American patients with glycogen-storage disease type II. American Journal of Human Genetics, 62, 991–994.

    Article  PubMed  CAS  Google Scholar 

  • Bendon, R. W., & Hug, G. (1985). Morphologic characteristics of the placenta in glycogen storage disease type II (alpha-1,4-glucosidase deficiency). American Journal of Obstetrics and Gynecology, 152, 1021–1026.

    PubMed  CAS  Google Scholar 

  • Bernstein, D. L., Bialere, M. G., Mehta, L., et al. (2010). Pompe disease: Dramatic improvement in gastrointestinal function following enzyme replacement therapy. A report of three late-onset patients. Molecular Genetics and Metabolism, 101(2–3), 130–133.

    Article  PubMed  CAS  Google Scholar 

  • Bodamer, O. A., Haas, D., Hermans, M. M., et al. (2002). L-alanine supplementation in late infantile glycogen storage disease type II. Pediatric Neurology, 27, 145–146.

    Article  PubMed  Google Scholar 

  • Bodamer, O. A., Halliday, D., & Leonard, J. V. (2000). The effects of l-alanine supplementation in late-onset glycogen storage disease type II. Neurology, 55, 710–712.

    PubMed  CAS  Google Scholar 

  • Boxer, R. A., Fishman, M., LaCorte, M. A., et al. (1986). Cardiac MR imaging in Pompe disease. Journal of Computer Assisted Tomography, 10, 857–859.

    Article  PubMed  CAS  Google Scholar 

  • Case, L. E., & Kishnani, P. S. (2006). Physical therapy management of Pompe disease. Genetics in Medicine, 8, 318–327.

    Article  PubMed  Google Scholar 

  • Chen, Y. T., & Amalfitano, A. (2000). Towards a molecular therapy for glycogen storage disease type II (Pompe disease). Molecular Medicine Today, 6, 245–251.

    Article  PubMed  CAS  Google Scholar 

  • Chien, Y.-H., Lee, N.-C., Thrberg, B. L., et al. (2009). Pompe disease in infants: Improving the prognosis by newborn screening program and early treatment. Pediatrics, 124, e1116–e1125.

    Article  PubMed  Google Scholar 

  • Cottrill, C. M., Johnson, G. L., & Noonan, J. A. (1987). Parental genetic contribution to mode of presentation in Pompe disease. Pediatrics, 79, 379–381.

    PubMed  CAS  Google Scholar 

  • De Dominicis, E., Finocchi, G., Vincenzi, M., et al. (1991). Echocardiographic and pulsed Doppler features in glycogen storage disease type II of the heart (Pompe’s disease). Acta Cardiologica, 46, 107–114.

    PubMed  Google Scholar 

  • Engel, A. G., Gomez, M. R., Seybold, M. E., et al. (1973). The spectrum and diagnosis of aced maltase deficiency. Neurology, 23, 95–106.

    PubMed  CAS  Google Scholar 

  • Haley, S. M., Fragala, M. A., & Skrinar, A. M. (2003). Pompe disease and physical disability. Developmental Medicine and Child Neurology, 45, 618–623.

    Article  PubMed  Google Scholar 

  • Hug, G. (1986). More on bone marrow transplantation for glycogen storage disease type II (Pompe’s disease). The New England Journal of Medicine, 315, 1229.

    PubMed  CAS  Google Scholar 

  • Hug, G., Soukup, S., Ryan, M., et al. (1984). Rapid prenatal diagnosis of glycogen-storage disease type II by electron microscopy of uncultured amniotic-fluid cells. The New England Journal of Medicine, 310, 1018–1022.

    Article  PubMed  CAS  Google Scholar 

  • Kikuchi, T., Yang, H. W., Pennybacker, M., et al. (1998). Clinical and metabolic correction of Pompe disease by enzyme therapy in acid maltase-deficient quail. The Journal of Clinical Investigation, 101, 827–833.

    Article  PubMed  CAS  Google Scholar 

  • Kishnani, P. S., Corzo, D., Nicolino, M., et al. (2007). Recombinant human acid [alpha]-glucosidase: Major clinical benefits in infantile-onset Pompe disease. Neurology, 68, 99–109.

    Article  PubMed  CAS  Google Scholar 

  • Kishnani, P. S., & Howell, R. R. (2004). Pompe disease in infants and children. Journal of Pediatrics, 144, S35–S43.

    Article  PubMed  CAS  Google Scholar 

  • Kishnani, P. S., Nicolino, M., Voit, T., et al. (2006). Chinese hamster ovary cell-derived recombinant human acid alpha-glucosidase in infantile-onset Pompe disease. Journal of Pediatrics, 149, 89–97.

    Article  PubMed  CAS  Google Scholar 

  • Kleijer, W. J., van der Kraan, M., Kroos, M. A., et al. (1995). Prenatal diagnosis of glycogen storage disease type II: Enzyme assay or mutation analysis? Pediatric Research, 38, 103–106.

    Article  PubMed  CAS  Google Scholar 

  • Klinge, L., Straub, V., Neudorf, U., et al. (2005). Safety and efficacy of recombinant acid alpha-glucosidase (rhGAA) in patients with classical infantile Pompe disease: Results of a phase II clinical trial. Neuromuscular Disorders, 15, 24–31.

    Article  PubMed  CAS  Google Scholar 

  • Laforêt, P., Nicolino, M., Eymard, B., et al. (2000). Juvenile and adult-onset acid maltase deficiency in France. Genotype-phenotype correlation. Neurology, 55, 1122–1128.

    PubMed  Google Scholar 

  • Lee, C. C., Chen, C. Y., Chou, T. Y., et al. (1996). Cerebral MR manifestations of Pompe disease in an infant. AJNR. American Journal of Neuroradiology, 17, 321–322.

    PubMed  CAS  Google Scholar 

  • Mehler, M., & DiMauro, S. (1977). Residual acid maltase activity in late-onset acid maltase deficiency. Neurology, 27, 178–184.

    PubMed  CAS  Google Scholar 

  • Meikle, P. J., Yan, M., Ravenscroft, E. M., et al. (1999). Altered trafficking and turnover of LAMP-1 in Pompe disease-affected cells. Molecular Genetics and Metabolism, 66, 179–188.

    Article  PubMed  CAS  Google Scholar 

  • Melvin, J. J. (2000). Pompe’s disease. Archives of Neurology, 57, 134–135.

    Article  PubMed  CAS  Google Scholar 

  • Nicolino, M. P., Puech, J. P., Kremer, E. J., et al. (1998). Adenovirus-mediated transfer of the acid alpha-glucosidase gene into fibroblasts, myoblasts and myotubes from patients with glycogen storage disease type II leads to high level expression of enzyme and corrects glycogen accumulation. Human Molecular Genetics, 7, 1695–1702.

    Article  PubMed  CAS  Google Scholar 

  • Noori, S., Acherman, R., Siassi, B., et al. (2002). A rare presentation of Pompe disease with massive hypertrophic cardiomyopathy at birth. Journal of Perinatal Medicine, 30, 517–521.

    Article  PubMed  Google Scholar 

  • Nyhan, W. L., & Sakati, N. A. (1987). Diagnostic recognition of genetic disease (pp. 198–205). Philadelphia, PA: Lea & Febiger.

    Google Scholar 

  • Phupong, V., Shuangshoti, S., Sutthiruangwong, P., et al. (2005). Prenatal diagnosis of Pompe disease by electron microscopy. Archives of Gynecology and Obstetrics, 271, 259–261.

    Google Scholar 

  • Poenaru, L. (2000). Approach to gene therapy of glycogenosis type II (Pompe disease). Molecular Genetics and Metabolism, 70, 163–169.

    Article  PubMed  CAS  Google Scholar 

  • Raben, N., Plotz, P., & Byrne, B. J. (2002). Acid alpha-glucosidase deficiency (glycogenosis type II, Pompe disease). Current Molecular Medicine, 2, 145–166.

    Article  PubMed  CAS  Google Scholar 

  • Reuser, A. J., Van Den Hout, H., Bijvoet, A. G., et al. (2002). Enzyme therapy for Pompe disease: From science to industrial enterprise. European Journal of Pediatrics, 161(Suppl 1), S106–111.

    PubMed  CAS  Google Scholar 

  • Schlenska, G. K., Heene, R., Spalke, G., et al. (1976). The symptomatology, morphology and biochemistry of glycogenosis type II (Pompe) in the adult. Journal of Neurology, 212, 237–252.

    Article  PubMed  CAS  Google Scholar 

  • Slonim, A. E., Bulone, L., Ritz, S., et al. (2000). Identification of two subtypes of infantile acid maltase deficiency. Journal of Pediatrics, 137, 283–285.

    Article  PubMed  CAS  Google Scholar 

  • Smit, G. P., Fernandes, J., & Leonard, J. V. (1990). The long-term outcome of patients with glycogen storage diseases. Journal of Inherited Metabolic Disease, 13, 411–418.

    Article  PubMed  CAS  Google Scholar 

  • Sun, B., Chen, Y. T., Bird, A., et al. (2003). Long-term correction of glycogen storage disease type II with a hybrid Ad-AAV vector. Molecular Therapy, 7, 193–201.

    Article  PubMed  CAS  Google Scholar 

  • Temple, J. K., Dunn, D. W., Blitzer, M. G., et al. (1985). The “muscular variant” of Pompe disease: Clinical, biochemical and histologic characteristics. American Journal of Medical Genetics, 21, 597–604.

    Article  PubMed  CAS  Google Scholar 

  • Umapathysivam, K., Hopwood, J. J., & Meikle, P. J. (2001). Determination of acid α-glucosidase activity in blood spots as a diagnostic test for Pompe disease. Clinical Chemistry, 47, 1378–1383.

    PubMed  CAS  Google Scholar 

  • Van den Hout, J. M., Reuser, A. J., de Klerk, J. B., et al. (2001). Enzyme therapy for Pompe disease with recombinant human alpha-glucosidase from rabbit milk. Journal of Inherited Metabolic Disease, 24, 266–274.

    Article  PubMed  Google Scholar 

  • Van den Hout, H., Reuser, A. J., Vulto, A. G., et al. (2000). Recombinant human α-glucosidase from rabbit milk in Pompe patients. Lancet, 356, 397–398.

    Article  PubMed  Google Scholar 

  • Vorgerd, M., Burwinkel, B., Reichmann, H., et al. (1998). Adult-onset glycogen storage disease type II: Phenotypic and allelic heterogeneity in German patients. Neurogenetics, 1, 205–211.

    Article  PubMed  CAS  Google Scholar 

  • Watson, J. G., Gardner-Medwin, D., Goldfinch, M. E., et al. (1986). Bone marrow transplantation for glycogen storage disease type II (Pompe’s disease). The New England Journal of Medicine, 314, 385.

    PubMed  CAS  Google Scholar 

  • Winkel, L. P. F., Kkamphoven, J. H. J., Hannerieke, J. M. P., et al. (2003). Morphological changes in muscle tissue of patients with infantile Pompe’s disease receiving enzyme replacement therapy. Muscle & Nerve, 27, 743–751.

    Article  CAS  Google Scholar 

  • Wolfsdorf, J. I., Holm, I. A., & Weinstein, D. A. (1999). Glycogen storage diseases. Phenotypic, genetic, and biochemical characteristics, and therapy. Endocrinology and Metabolism Clinics of North America, 28, 801–823.

    Article  PubMed  CAS  Google Scholar 

Download references

Editor information

Editors and Affiliations

  1. Perinatal and Clinical Genetics, Department of Pediatrics, LSU Health Sciences Center, 1501 Kings Highway, Shreveport, LA, 71130, USA

    Harold Chen

Rights and permissions

Reprints and permissions

Copyright information

© 2012 Springer Science+Business Media, LLC

About this entry

Cite this entry

(2012). Glycogen Storage Disease, Type II. In: Chen, H. (eds) Atlas of Genetic Diagnosis and Counseling. Springer, New York, NY. https://doi.org/10.1007/978-1-4614-1037-9_108

Download citation

Publish with us

Policies and ethics

Search

Navigation